Effect of a unani herb in Female Sexual disorders

Effect of Behman Surkh in Female Sexual Dysfunction: A pilot study

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/01/049318

Enrollment

Registered

2023-01-31

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N941- Dyspareunia

Interventions

Intervention1: Behman surkh (Salvia Haematodes Linn): Orally 3.5 g powder will be given twice a day with milk for day 60 days. Control Intervention1: Roasted rice.: Orally 3.5 g powder will be given t

Eligibility

Inclusion criteria

Inclusion criteria: Experiencing Sexual Dysfunction (dyspareunia, loss of libido, lack of lubrication, decrease desire etc.). Female sexual function Index (FSFI) score = 26.55 before this study

Exclusion criteria

Exclusion criteria: If they had received hormone therapy within 3 months of recruitment. Pregnant and breastfeeding within 3 months before the study. Serious illnesses, breast, endometrial, or other gynecological malignancies

Design outcomes

Primary

Measure	Time frame
The primary outcome will be a change in FSFI (female sexual function index) scale before and after treatmentTimepoint: Before and after treatment	—

Secondary

Measure	Time frame
Perceived Stress Scale (PSS). Patient’s Global Assessment of Response to Therapy (PGART), FIEI (Female intervention efficacy index) & Patients Global Assessment of Tolerability to Therapy (PGATT)Timepoint: Before and after treatment	—

Countries

India

Contacts

Public ContactARSHIYA SULTANA

National Institute of Unani Medicine

drarshiya@yahoo.com09740915911

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026